Octreotide
NDC 63323-377 · Fresenius Kabi USA, LLC
FDA carries 2 listing records for this NDC; the most recent is shown.
Packages
63323-377-01 — 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-377-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-377-00)
63323-377-04 — 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-377-04) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-377-41)
Billed under HCPCS
J2354 — Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg Medicare Part B payment limit (ASP + 6%): $0.60
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0641-6177 — Octreotide Acetate, 0641-6178 — Octreotide Acetate, 23155-685 — octreotide acetate, 23155-686 — octreotide acetate, 23155-687 — octreotide acetate, 23155-688 — octreotide acetate, 23155-689 — octreotide acetate, 52958-046 — octreotide acetate, 62756-452 — octreotide acetate, 63323-376 — OCTREOTIDE ACETATE, 63323-378 — OCTREOTIDE ACETATE, 63323-379 — OCTREOTIDE ACETATE, 67457-239 — octreotide acetate, 67457-245 — octreotide acetate, 67457-246 — octreotide acetate, 68083-515 — Octreotide Acetate, 68083-516 — Octreotide Acetate, 68083-517 — Octreotide Acetate, 68083-560 — Octreotide Acetate, 68462-896 — Octreotide Acetate, +10 more
Poisoning, adverse-effect and underdosing codes for this drug
The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.
T38.991 — Poisoning by other hormone antagonists, accidental (unintentional), T38.992 — Poisoning by other hormone antagonists, intentional self-harm, T38.993 — Poisoning by other hormone antagonists, assault, T38.994 — Poisoning by other hormone antagonists, undetermined, T38.995 — Adverse effect of other hormone antagonists, T38.996 — Underdosing of other hormone antagonists